NCT01447784View on ClinicalTrials.gov

ToleroMune House Dust Mites (HDM) Exposure Chamber Study

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Rhinoconjunctivitis
Interventions
BIOLOGICAL

ToleroMune HDM

Intradermal injection 1 x 11 administrations 4 weeks apart

BIOLOGICAL

Placebo

Intradermal injection 1 x 11 administrations 4 weeks apart

Trial Locations (1)

L4W 1N2

Cetero Research, Mississauga

Sponsors
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Cetero Research, San Antonio

NETWORK

lead

Circassia Limited

INDUSTRY